Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Q32 Bio (QTTB) Operating Expenses (2018 - 2025)

Historic Operating Expenses for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to $7.6 million.

  • Q32 Bio's Operating Expenses fell 5972.68% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.5 million, marking a year-over-year decrease of 3064.43%. This contributed to the annual value of $66.1 million for FY2024, which is 5888.38% up from last year.
  • Q32 Bio's Operating Expenses amounted to $7.6 million in Q3 2025, which was down 5972.68% from $9.2 million recorded in Q2 2025.
  • Q32 Bio's 5-year Operating Expenses high stood at $38.4 million for Q1 2022, and its period low was $7.6 million during Q3 2025.
  • For the 5-year period, Q32 Bio's Operating Expenses averaged around $21.2 million, with its median value being $17.9 million (2024).
  • In the last 5 years, Q32 Bio's Operating Expenses plummeted by 7313.9% in 2023 and then soared by 9482.24% in 2024.
  • Quarter analysis of 5 years shows Q32 Bio's Operating Expenses stood at $34.4 million in 2021, then increased by 2.52% to $35.3 million in 2022, then plummeted by 68.42% to $11.1 million in 2023, then skyrocketed by 30.31% to $14.5 million in 2024, then tumbled by 47.84% to $7.6 million in 2025.
  • Its Operating Expenses stands at $7.6 million for Q3 2025, versus $9.2 million for Q2 2025 and $12.2 million for Q1 2025.